CRIS: Expands Clinical Sites
Curis expands clinical sites in TakeAim CLL study and reaffirms patient dosing guidance
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Curis expands clinical sites in TakeAim CLL study and reaffirms patient dosing guidance
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.